Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Metastases × Clear all

Phase

Status

Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1593 Neoplasms 1086 Colorectal Neoplasms 906 Carcinoma, Non-Small-Cell Lung 883 Stomach Neoplasms 695 Carcinoma, Hepatocellular 695 Lung Neoplasms 666 Prostatic Neoplasms 604 Pancreatic Neoplasms 494 Rectal Neoplasms 378 Neoplasm Metastasis 362 Ovarian Neoplasms 351 Colonic Neoplasms 350 Recurrence 338 Uterine Cervical Neoplasms 335 Leukemia, Myeloid, Acute 328 Esophageal Neoplasms 297 Multiple Myeloma 295 Head and Neck Neoplasms 286 Lymphoma 285 Melanoma 274 Brain Neoplasms 239 Precursor Cell Lymphoblastic Leukemia-Lymphoma 238 Urinary Bladder Neoplasms 224 Nasopharyngeal Carcinoma 195 Lymphoma, Large B-Cell, Diffuse 195 Leukemia 194 Liver Neoplasms 187 Polycystic Ovary Syndrome 180 Squamous Cell Carcinoma of Head and Neck 174

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03932071 2019-05-06

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown

Lung Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡